Alde Medi Impex Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 4.17 Cr
as on 15-06-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.94 Cr
as on 15-06-2024
- Satisfied Charges ₹ 6.71 Cr
as on 15-06-2024
- Revenue 36.17%
(FY 2023)
- Profit 120.06%
(FY 2023)
- Ebitda 53.71%
(FY 2023)
- Net Worth 31.83%
(FY 2023)
- Total Assets 26.42%
(FY 2023)
About Alde Medi Impex
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.17 Cr.
The company currently has active open charges totaling ₹10.94 Cr. The company has closed loans amounting to ₹6.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mehul Rastogi, Manas Rastogi, and Rajesh Rastogi serve as directors at the Company.
- CIN/LLPIN
U24231DL1997PLC085614
- Company No.
085614
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Mar 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alde Medi Impex Limited offer?
Alde Medi Impex Limited offers a wide range of products and services, including Protein Supplements, Amino Acids, Immunity Boosters, Vitamin C.
Who are the key members and board of directors at Alde Medi Impex?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manas Rastogi  | Director | 12-Aug-2014 | Current |
| Mehul Rastogi | Director | 12-Aug-2014 | Current |
| Rajesh Rastogi | Director | 05-Mar-1997 | Current |
Financial Performance of Alde Medi Impex.
Alde Medi Impex Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.17% increase. The company also saw a substantial improvement in profitability, with a 120.06% increase in profit. The company's net worth Soared by an impressive increase of 31.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alde Medi Impex?
In 2023, Alde Medi Impex had a promoter holding of 46.56% and a public holding of 53.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alde Expression Lifesciences Private LimitedActive 2 years 8 monthsMehul Rastogi and Manas Rastogi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Nov 2022 | ₹3.04 M | Open |
Others Creation Date: 11 Nov 2022 | ₹3.60 M | Open |
Others Creation Date: 02 Nov 2022 | ₹10.00 Cr | Open |
How Many Employees Work at Alde Medi Impex?
Alde Medi Impex has a workforce of 157 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alde Medi Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alde Medi Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
